person · Reporting owner

Braunstein Douglas L

Disclosed activity across 9 companies

Tapewire entity: 12767
SEC CIK: 0001495110

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CANTALOUPE, INC.CTLP · Entity 45433	10% owner	February 20, 2024	February 22, 2024
Cardtronics plcCATM · Entity 138760	10% owner	March 09, 2021	March 11, 2021
EAGLE PHARMACEUTICALS, INC.EGRX · Entity 85958	Director	October 24, 2019	October 28, 2019
Hudson Executive Investment Corp. IIHCII · Entity 130674	Director · President, Chairman	February 07, 2022	February 09, 2022
Hudson Executive Investment Corp. IIIHIII · Entity 129488	Director · President, Chairman	March 02, 2022	March 04, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CANTALOUPE, INC.

Report date February 20, 2024 · Filed February 22, 2024

Jointly reported with Hudson Executive Capital LP, HEC Management GP LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	9,270,694	Last balance in matching sequence After 2023-02-21 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2023-02-20 · Other · Disposed 2,884,584 · Balance 9,361,276 F1: This filing reports in-kind distribution of Issuer shares to the limited partners of special purpose vehicle HEC SPV IV LP. No consideration was paid in connection with these distributions. To further facilitate the return of capital to those limited partners, the Reporting Persons (defined below) sold 90,582 Issuer shares, including certain legended shares, and intent to distribute the net proceeds from those sales to the limited partners. The Reporting Persons have no current plans to sell any other shares of this Issuer but reserve their right to do so in their discretion. F2: In addition to Hudson Executive Capital LP ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Row 2 · 2023-02-21 · Sale · Disposed 90,582 · Balance 9,270,694 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions through a broker-dealer at prices ranging from $6.22 to $6.53, inclusive. The Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2: In addition to Hudson Executive Capital LP ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Common StockSEC Table I · non-derivative	Direct	20,212	Reported balance Holding disclosure · report date 2024-02-20 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 20,212 F6: These securities are directly owned by Douglas L. Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.

Filing footnotes · ownership attribution and instrument terms

F1: This filing reports in-kind distribution of Issuer shares to the limited partners of special purpose vehicle HEC SPV IV LP. No consideration was paid in connection with these distributions. To further facilitate the return of capital to those limited partners, the Reporting Persons (defined below) sold 90,582 Issuer shares, including certain legended shares, and intent to distribute the net proceeds from those sales to the limited partners. The Reporting Persons have no current plans to sell any other shares of this Issuer but reserve their right to do so in their discretion.

F2: In addition to Hudson Executive Capital LP ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities").

F3: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).

F4: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions through a broker-dealer at prices ranging from $6.22 to $6.53, inclusive. The Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F6: These securities are directly owned by Douglas L. Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.

Cardtronics plc

Report date March 09, 2021 · Filed March 11, 2021

Jointly reported with Hudson Executive Capital LP, HEC Management GP LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnote	14,040	Reported balance After 2021-03-09 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-03-09 · Exercise / conversion · Acquired 5,952 · Balance 14,040 F1: Restricted Stock Units awarded on March 31, 2020. Restricted Stock Units converted into ordinary shares upon vesting in accordance with the Restricted Stock Unit Award Agreement. F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.
Restricted Stock UnitsSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2021-03-09 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-03-09 · Exercise / conversion · Disposed 5,952 · Balance 0 F1: Restricted Stock Units awarded on March 31, 2020. Restricted Stock Units converted into ordinary shares upon vesting in accordance with the Restricted Stock Unit Award Agreement. F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.
Restricted Stock UnitsSEC Table II · derivative / convertible security	IndirectSee footnote	3,491	Reported balance After 2021-03-10 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-03-10 · Grant · Acquired 3,491 · Balance 3,491 F7: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2022, and each Restricted Stock Unit will convert into one share of Cardtronics common stock at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnotes	8,644,880	Reported balance Holding disclosure · report date 2021-03-09 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 8,644,880 F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F6: Mr. Braunstein, a member of the board of directors of the Company, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Units awarded on March 31, 2020. Restricted Stock Units converted into ordinary shares upon vesting in accordance with the Restricted Stock Unit Award Agreement.

F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.

F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities").

F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).

F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F6: Mr. Braunstein, a member of the board of directors of the Company, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934.

F7: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2022, and each Restricted Stock Unit will convert into one share of Cardtronics common stock at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company.

EAGLE PHARMACEUTICALS, INC.

Report date October 24, 2019 · Filed October 28, 2019

Jointly reported with Hudson Executive Capital LP, HEC Management GP LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	732,777	Last balance in matching sequence After 2019-10-25 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2019-10-24 · Sale · Disposed 1,494 · Balance 748,214 F1: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $62.5600, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Row 2 · 2019-10-25 · Sale · Disposed 15,437 · Balance 732,777 F1: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F6: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $64.1300, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c).

F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $62.5600, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $64.1300, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.

Hudson Executive Investment Corp. II

Report date February 07, 2022 · Filed February 09, 2022

Jointly reported with HEC Sponsor II LLC, Bergeron Douglas

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table II · derivative / convertible security	Direct	6,190,000	Reported balance After 2022-02-07 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2022-02-07 · Sale · Disposed 20,000 · Balance 6,190,000 F1: The shares of Class B common stock are convertible for shares of the Issuer's Class A common stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-251848) (the "Registration Statement") and have no expiration date. F2: HEC Sponsor II LLC is the record holder of the securities reported herein. Douglas G. Bergeron and Douglas L. Braunstein are among the managers of HEC Sponsor II LLC and share voting and investment discretion with respect to the securities held of record by HEC Sponsor II LLC. Mr. Braunstein and Mr. Bergeron disclaim any beneficial ownership of the securities held by HEC Sponsor II LLC other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of Class B common stock are convertible for shares of the Issuer's Class A common stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-251848) (the "Registration Statement") and have no expiration date.

F2: HEC Sponsor II LLC is the record holder of the securities reported herein. Douglas G. Bergeron and Douglas L. Braunstein are among the managers of HEC Sponsor II LLC and share voting and investment discretion with respect to the securities held of record by HEC Sponsor II LLC. Mr. Braunstein and Mr. Bergeron disclaim any beneficial ownership of the securities held by HEC Sponsor II LLC other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Hudson Executive Investment Corp. III

Report date March 02, 2022 · Filed March 04, 2022

Jointly reported with HEC Sponsor III LLC, Bergeron Douglas

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table II · derivative / convertible security	Direct	14,925,000	Reported balance After 2022-03-02 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2022-03-02 · Purchase · Acquired 25,000 · Balance 14,925,000 F1: The shares of Class B common stock are convertible for shares of the Issuer's Class A common stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-252744) (the "Registration Statement") and have no expiration date. F2: The aggregate price paid for the transferred shares was $41.67. F3: HEC Sponsor III LLC is the record holder of the securities reported herein. Douglas G. Bergeron and Douglas L. Braunstein are among the managers of HEC Sponsor III LLC and share voting and investment discretion with respect to the securities held of record by HEC Sponsor III LLC. Mr. Braunstein and Mr. Bergeron disclaim any beneficial ownership of the securities held by HEC Sponsor III LLC other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of Class B common stock are convertible for shares of the Issuer's Class A common stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-252744) (the "Registration Statement") and have no expiration date.

F2: The aggregate price paid for the transferred shares was $41.67.

F3: HEC Sponsor III LLC is the record holder of the securities reported herein. Douglas G. Bergeron and Douglas L. Braunstein are among the managers of HEC Sponsor III LLC and share voting and investment discretion with respect to the securities held of record by HEC Sponsor III LLC. Mr. Braunstein and Mr. Bergeron disclaim any beneficial ownership of the securities held by HEC Sponsor III LLC other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Past disclosures · reporting ended (4)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Corindus Vascular Robotics, Inc.

Report date October 29, 2019 · Filed October 31, 2019

Section 16 reporting ended · disclosed 2019-10-31. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2019-10-29 transaction · row 1 1 source row Row 1 · 2019-10-29 · Disposition to issuer · Disposed 106,219 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2: These shares represent 85,482 shares of the Issuer's common stock and 20,737 restricted stock units ("RSUs"). F3: At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes. F4: At the Effective Time, each outstanding RSU converted into the right to receive a cash payment equal to the product of (i) $4.28 and (ii) the number of shares of the Issuer's common stock underlying the RSU as of the Effective Time, without interest and net of any applicable withholding taxes.
Common StockSEC Table I · non-derivative	IndirectSee footnote	Reported balance After 2019-10-29 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2019-10-29 · Disposition to issuer · Disposed 14,235,545 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F3: At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes. F5: Securities were directly owned by Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported except to the extent of any pecuniary interest therein.
Series A Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.25	IndirectSee footnote	Reported balance After 2019-10-29 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-10-29 · Disposition to issuer · Disposed 540,000 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F8: At the Effective Time, each outstanding share of the Issuer's Series A Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes. F6: The holders of shares of Series A Preferred Stock and Series A-1 Preferred Stock had the right, at any time and from time to time, at such holder's option, to convert all or any portion of such holder's shares of Series A Preferred Stock or Series A-1 Preferred Stock into fully paid and non-assessable shares of the Issuer's common stock. F7: The Series A Preferred Stock and Series A-1 Preferred Stock were perpetual and therefore had no expiration date. F5: Securities were directly owned by Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported except to the extent of any pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.25	IndirectSee footnote	Reported balance After 2019-10-29 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-10-29 · Disposition to issuer · Disposed 105,281.218 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F9: At the Effective Time, each outstanding share of the Issuer's Series A-1 Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes. F6: The holders of shares of Series A Preferred Stock and Series A-1 Preferred Stock had the right, at any time and from time to time, at such holder's option, to convert all or any portion of such holder's shares of Series A Preferred Stock or Series A-1 Preferred Stock into fully paid and non-assessable shares of the Issuer's common stock. F7: The Series A Preferred Stock and Series A-1 Preferred Stock were perpetual and therefore had no expiration date. F5: Securities were directly owned by Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported except to the extent of any pecuniary interest therein.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.40 · Expires 2028-03-16	IndirectSee footnote	Reported balance After 2019-10-29 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-10-29 · Disposition to issuer · Disposed 4,725,000 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F10: At the Effective Time, each outstanding warrant to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment (without interest) equal to (i) the product of (a) the excess, if any, of (1) $4.28 over (2) the per share exercise price of such warrant, and (b) the number of shares of the Issuer's common stock subject to such warrant as of the Effective Time, less (ii) any applicable withholding taxes. F5: Securities were directly owned by Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported except to the extent of any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").

F2: These shares represent 85,482 shares of the Issuer's common stock and 20,737 restricted stock units ("RSUs").

F3: At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes.

F4: At the Effective Time, each outstanding RSU converted into the right to receive a cash payment equal to the product of (i) $4.28 and (ii) the number of shares of the Issuer's common stock underlying the RSU as of the Effective Time, without interest and net of any applicable withholding taxes.

F5: Securities were directly owned by Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported except to the extent of any pecuniary interest therein.

F6: The holders of shares of Series A Preferred Stock and Series A-1 Preferred Stock had the right, at any time and from time to time, at such holder's option, to convert all or any portion of such holder's shares of Series A Preferred Stock or Series A-1 Preferred Stock into fully paid and non-assessable shares of the Issuer's common stock.

F7: The Series A Preferred Stock and Series A-1 Preferred Stock were perpetual and therefore had no expiration date.

F8: At the Effective Time, each outstanding share of the Issuer's Series A Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes.

F9: At the Effective Time, each outstanding share of the Issuer's Series A-1 Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes.

F10: At the Effective Time, each outstanding warrant to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment (without interest) equal to (i) the product of (a) the excess, if any, of (1) $4.28 over (2) the per share exercise price of such warrant, and (b) the number of shares of the Issuer's common stock subject to such warrant as of the Effective Time, less (ii) any applicable withholding taxes.

JPMORGAN CHASE & CO

Report date December 17, 2012 · Filed January 04, 2013

Section 16 reporting ended · disclosed 2013-01-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	470,836	Ending reported balance After 2012-12-26 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2012-12-17 · Gift · Disposed 24,000 · Balance 579,836 Row 2 · 2012-12-26 · Gift · Disposed 109,000 · Balance 470,836
Common StockSEC Table I · non-derivative	IndirectBy Spouse	24,000	Reported balance After 2012-12-17 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2012-12-17 · Gift · Acquired 24,000 · Balance 24,000
Common StockSEC Table I · non-derivative	IndirectBy Spouse	0	Reported balance After 2012-12-21 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2012-12-21 · Gift · Disposed 24,000 · Balance 0
Common StockSEC Table I · non-derivative	IndirectBy Spouse's Trust for Children	24,000	Reported balance After 2012-12-21 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 5 · 2012-12-21 · Gift · Acquired 24,000 · Balance 24,000
Common StockSEC Table I · non-derivative	IndirectBy Trust for children	109,000	Reported balance After 2012-12-26 transaction · row 6 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 6 · 2012-12-26 · Gift · Acquired 109,000 · Balance 109,000
Common StockSEC Table I · non-derivative	IndirectBy 401(k)	479.999	Reported balance Holding disclosure · report date 2012-12-17 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 479.999

TIVITY HEALTH, INC.

Report date May 07, 2020 · Filed May 11, 2020

Jointly reported with Hudson Executive Capital LP, HEC Management GP LLC

Section 16 reporting ended · disclosed 2020-05-11. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	4,795,310	Reported balance After 2020-05-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2020-05-07 · Disposition to issuer · Disposed 3,960,000 · Balance 4,795,310 F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Short Call Option (obligation to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2020-08-21	IndirectSee footnotes	0	Reported balance After 2020-05-07 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-05-07 · Other · Acquired 43,776 · Balance 0 F4: Order executed by the Reporting Persons to close out the outstanding short call option (obligation to sell) for 4,377,600 shares of common stock of Tivity Health, Inc., as reported by the Reporting Persons on a Form 3 filed with the Securities and Exchange Commission on March 13, 2020. F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Long Put Option (right to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2020-08-21	IndirectSee footnotes	0	Reported balance After 2020-05-07 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-05-07 · Disposition to issuer · Disposed 43,776 · Balance 0 F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities").

F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).

F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F4: Order executed by the Reporting Persons to close out the outstanding short call option (obligation to sell) for 4,377,600 shares of common stock of Tivity Health, Inc., as reported by the Reporting Persons on a Form 3 filed with the Securities and Exchange Commission on March 13, 2020.

Talkspace, Inc.

Report date August 17, 2026 · Filed August 17, 2026

Section 16 reporting ended · disclosed 2026-08-17. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2026-08-17 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-08-17 · Disposition to issuer · Disposed 2,038,612 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F2: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration").
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2026-08-17 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2026-08-17 · Disposition to issuer · Disposed 891,583 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F2: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration"). F3: These securities are jointly held by Mr. Braunstein and Samara Braunstein.
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2026-08-17 transaction · row 5 Account or security details depend on footnotes; rows are not merged. 1 source row Row 5 · 2026-08-17 · Disposition to issuer · Disposed 48,222 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer restricted stock unit that was or became vested in accordance with its terms at the Effective Time (each, a "Vested RSU") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
Common StockSEC Table I · non-derivative	IndirectBy Braunstein 2015 Trust	Reported balance After 2026-08-17 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-08-17 · Disposition to issuer · Disposed 700,529 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F2: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration"). F3: These securities are jointly held by Mr. Braunstein and Samara Braunstein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	Reported balance After 2026-08-17 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2026-08-17 · Disposition to issuer · Disposed 9,795,600 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F2: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration"). F4: Hudson Executive Capital LP ("Hudson Executive"), as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the securities reported on this Form 4 (the "Subject Securities") for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934 (the "Exchange Act"). HEC Management GP LLC ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act. Mr. Braunstein disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.22	Direct	Reported balance After 2026-08-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2026-08-17 · Disposition to issuer · Disposed 640,000 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F6: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $8.52	Direct	Reported balance After 2026-08-17 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2026-08-17 · Disposition to issuer · Disposed 63,402 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F7: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Vested Stock Option reported in this row had an exercise price equal to or greater than the Merger Consideration and was canceled for no consideration.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time").

F2: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration").

F3: These securities are jointly held by Mr. Braunstein and Samara Braunstein.

F4: Hudson Executive Capital LP ("Hudson Executive"), as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the securities reported on this Form 4 (the "Subject Securities") for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934 (the "Exchange Act"). HEC Management GP LLC ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act. Mr. Braunstein disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer restricted stock unit that was or became vested in accordance with its terms at the Effective Time (each, a "Vested RSU") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested RSU immediately prior to the Effective Time and (ii) the Merger Consideration.

F6: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option.

F7: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Vested Stock Option reported in this row had an exercise price equal to or greater than the Merger Consideration and was canceled for no consideration.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 05, 2019 Filed Aug 5, 2019 21:18 UTC	CANTALOUPE, INC. USAT · Entity 45433	SaleShort Put Option (obligation to buy) · Derivative	5,300	$1.40 Strike: $7.00	$7,420.00	Disclosure SEC source: 0001567619-19-015815 · doc1.xml · derivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2020-03-20 F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
August 05, 2019 Filed Mar 6, 2020 21:36 UTC Amendment	CANTALOUPE, INC. USAT · Entity 45433	SaleShort Put Option (obligation to buy) · Derivative	5,300	$1.40 Strike: $7.00	$7,420.00	Disclosure SEC source: 0001567619-20-005830 · doc1.xml · derivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,300 Underlying: Common Stock · 530,000 shares Expires 2020-03-20 F1 · derivative.underlying_shares: This amended report is being filed to correct the number of shares of common stock of USA Technologies Inc. underlying the short put options, from 5,300 to 530,000, sold by the Reporting Persons (defined below) on August 5, 2019. F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 amendment is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 amendment (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
August 01, 2019 Filed Aug 5, 2019 21:18 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCommon Stock	1,000,252	$6.93	$6,931,746.36	Disclosure SEC source: 0001567619-19-015815 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,195,972 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $6.60 to $6.93, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
July 08, 2019 Filed Jul 10, 2019 22:06 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	1,453	$3.44	$4,998.32	Disclosure SEC source: 0001387131-19-004966 · braunstein-form4_070819.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,049 F1 · shares: The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. ("Corindus") Director Compensation Policy in lieu of the reporting person's quarterly board retainer of $5,000. F2 · balance_after: Includes 27,649 shares of common stock related to RSUs granted as part of the director's 2019 annual equity award which provided for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020, and May 3, 2020, subject to the reporting person's continuous service with Corindus through each such vesting date. Read SEC document
May 10, 2019 Filed May 13, 2019 17:52 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	100,000	$56.14	$5,614,000.00	Disclosure SEC source: 0001567619-19-010640 · doc1.xml · nonDerivative · entry 2 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 811,777 F2 · ownership.nature: These securities are held for the account of certain private investment funds (the "HEC Funds") for which Hudson Executive Capital LP, a Delaware limited partnership ("HEC"), acts as investment adviser. The Reporting Person controls the general partner of HEC and indirectly controls the general partner of the HEC Funds. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them. Read SEC document
May 09, 2019 Filed May 13, 2019 17:52 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	59,223	$57.95	$3,431,972.85	Disclosure SEC source: 0001567619-19-010640 · doc1.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 911,777 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $57.94 to $58.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. F2 · ownership.nature: These securities are held for the account of certain private investment funds (the "HEC Funds") for which Hudson Executive Capital LP, a Delaware limited partnership ("HEC"), acts as investment adviser. The Reporting Person controls the general partner of HEC and indirectly controls the general partner of the HEC Funds. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them. Read SEC document
May 03, 2019 Filed May 7, 2019 22:34 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	27,649	$2.17	$59,998.33	Disclosure SEC source: 0001387131-19-003399 · braunstein-form4_050319.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,596 F1 · shares: The common stock represents shares issuable upon vesting of restricted stock units (RSUs) granted as part of the director's 2019 annual equity award. The RSUs provide for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020 and May 3, 2020, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. (Corindus) through each such vesting date. F2 · balance_after: Includes 53,326 shares of common stock related to RSUs granted as part of the director's 2018 annual equity award which provided for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. Read SEC document
April 05, 2019 Filed Apr 9, 2019 22:13 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	2,358	$2.12	$4,998.96	Disclosure SEC source: 0001387131-19-002572 · braunstein-form4_040519.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,947 F1 · shares: The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. ("Corindus") Director Compensation Policy in lieu of the reporting person's quarterly retainer of $5,000. F2 · balance_after: Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted to Mr. Braunstein, a member of the board of directors of Corindus, as part of his 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to Mr. Braunstein's continuous service with Corindus through each such vesting date. Read SEC document
March 13, 2019 Filed Mar 15, 2019 20:53 UTC	Cardtronics plc CATM · Entity 138760	GrantRestricted Stock Units · Derivative	4,278	Not disclosed	Not disclosed	Disclosure SEC source: 0001567619-19-007016 · doc1.xml · derivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,278 Underlying: Ordinary Shares · 4,278 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Cardtronics ordinary shares and are awarded under the Issuer's current Stock Incentive Plan and subject to the terms of a Restricted Stock Unit Agreement. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Cardtronics ordinary shares and are awarded under the Issuer's current Stock Incentive Plan and subject to the terms of a Restricted Stock Unit Agreement. F2 · derivative.exercise_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Issuer for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2020. In the event Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Issuer. F2 · derivative.expiration_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Issuer for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2020. In the event Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Issuer. F2 · ownership.direct: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Issuer for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2020. In the event Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Issuer. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F6 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
March 12, 2019 Filed Mar 14, 2019 21:47 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	PurchaseCommon Stock	2,899,391	$1.38	$3,999,999.82	Disclosure SEC source: 0001567619-19-006905 · doc1.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,235,545 F1 · ownership.nature: Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein. Read SEC document
March 08, 2019 Filed Mar 12, 2019 15:45 UTC	Cardtronics plc CATM · Entity 138760	Exercise / conversionRestricted Stock Units · Derivative	3,810	Not disclosed	Not disclosed	Disclosure SEC source: 0001567619-19-006652 · doc1.xml · derivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Ordinary Shares · 3,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F1 · shares: Restricted stock units converted into ordinary shares upon vesting. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F3 · derivative.exercise_date: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F3 · derivative.expiration_date: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F3 · ownership.direct: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F4 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F5 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F6 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F7 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
March 08, 2019 Filed Mar 12, 2019 15:45 UTC	Cardtronics plc CATM · Entity 138760	Exercise / conversionOrdinary Shares	3,810	Not disclosed	Not disclosed	Disclosure SEC source: 0001567619-19-006652 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,130,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units converted into ordinary shares upon vesting. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F3 · ownership.direct: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F4 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F5 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F6 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F7 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
January 23, 2019 Filed Jan 25, 2019 21:24 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	GrantStock Option (right to buy) · Derivative	10,000	$0.00 Strike: $42.40	$0.00	Disclosure SEC source: 0001209191-19-005454 · doc4.xml · derivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The option fully vests on January 23, 2020, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. Read SEC document
January 08, 2019 Filed Jan 10, 2019 22:36 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	5,357	$1.12	$5,999.84	Disclosure SEC source: 0001387131-19-000164 · ownership.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,589 F1 · shares: The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. ("Corindus") Director Compensation Policy in lieu of the retainer due to the reporting person in the amount of $6,000. F2 · balance_after: Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. F3 · balance_after: Includes 6,780 shares of common stock related to RSUs granted as part of the director's 2017 annual equity award with vesting beginning as of March 16, 2018, the date of the reporting person's appointment as a director. The RSUs vest in four quarterly installments on June 16, 2018, September 16, 2018, December 16, 2018 and March 16, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. Read SEC document
October 05, 2018 Filed Oct 9, 2018 23:00 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	3,200	$1.25	$4,000.00	Disclosure SEC source: 0001387131-18-005356 · braunstein-form4_100518.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,232 F1 · shares: The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. ("Corindus") Director Compensation Policy in lieu of the reporting person's quarterly retainer of $4,000. F2 · balance_after: Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. F3 · balance_after: Includes 6,780 shares of common stock related to RSUs granted as part of the director's 2017 annual equity award with vesting beginning as of March 16, 2018, the date of the reporting person's appointment as a director. The RSUs vest in four quarterly installments on June 16, 2018, September 16, 2018, December 16, 2018 and March 16, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. Read SEC document
August 13, 2018 Filed Aug 15, 2018 17:00 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	54,898	$29.89	$1,640,901.22	Disclosure SEC source: 0001567619-18-001200 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,126,933 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $29.68 to $30.00. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
August 10, 2018 Filed Aug 10, 2018 17:28 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	12,350	$30.22	$373,217.00	Disclosure SEC source: 0001567619-18-000430 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · Director · 10% owner Braunstein Douglas L · CIK 0001495110 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,072,035 F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $30.00 to $30.42. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
August 08, 2018 Filed Aug 10, 2018 17:28 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	12,850	$29.73	$382,030.50	Disclosure SEC source: 0001567619-18-000430 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · Director · 10% owner Braunstein Douglas L · CIK 0001495110 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,059,685 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $29.50 to $29.97. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 and footnote 6 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
July 09, 2018 Filed Jul 12, 2018 00:47 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	4,273	$1.17	$4,999.41	Disclosure SEC source: 0001387131-18-003103 · braunstein-form4_070918.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,032 F1 · shares: The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. ("Corindus") Director Compensation Policy in lieu of the reporting person's quarterly retainer of $5,000. F2 · balance_after: Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. F3 · balance_after: Includes 6,780 shares of common stock related to RSUs granted as part of the director's 2017 annual equity award with vesting beginning as of March 16, 2018, the date of the reporting person's appointment as a director. The RSUs vest in four quarterly installments on June 16, 2018, September 16, 2018, December 16, 2018 and March 16, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. Read SEC document
June 20, 2018 Filed Jun 22, 2018 17:41 UTC	Cardtronics plc CATM · Entity 138760	GrantRestricted Stock Units · Derivative	3,810	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-18-029644 · doc1.xml · derivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,810 Underlying: Ordinary Shares · 3,810 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F2 · derivative.exercise_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units shall lapse on March 8, 2019, and each restricted stock unit will convert into one share of Cardtronics ordinary shares at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F2 · derivative.expiration_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units shall lapse on March 8, 2019, and each restricted stock unit will convert into one share of Cardtronics ordinary shares at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F2 · ownership.direct: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units shall lapse on March 8, 2019, and each restricted stock unit will convert into one share of Cardtronics ordinary shares at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F3 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F6 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:00 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	53,326	$0.75	$39,999.83	Disclosure SEC source: 0001387131-18-002520 · braunstein-form4_053118.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,759 F1 · shares: The common stock represents shares issuable upon vesting of restricted stock units (RSUs) granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. (Corindus) through each such vesting date. F2 · balance_after: Includes 6,780 shares of common stock related to RSUs granted as part of the director's 2017 annual equity award with vesting beginning as of March 16, 2018, the date of the reporting person's appointment as a director. The RSUs vest in four equal quarterly installments on June 16, 2018, September 16, 2018, December 16, 2018 and March 16, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date. Read SEC document
May 03, 2018 Filed May 4, 2018 17:08 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	24,000	$25.34	$608,160.00	Disclosure SEC source: 0001140361-18-021786 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,046,835 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $24.95 to $25.65. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
May 02, 2018 Filed May 4, 2018 17:08 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	119,000	$25.32	$3,013,080.00	Disclosure SEC source: 0001140361-18-021786 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,022,835 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.01 to $25.70. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 5 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 27, 2018 Filed Apr 30, 2018 18:48 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	122,150	$25.92	$3,166,128.00	Disclosure SEC source: 0001140361-18-020589 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,903,835 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.65 to $26.03. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 26, 2018 Filed Apr 30, 2018 18:48 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	85,000	$25.87	$2,198,950.00	Disclosure SEC source: 0001140361-18-020589 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,781,685 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.73 to $26.05. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 5 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 20, 2018 Filed Apr 24, 2018 17:18 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	350,500	$25.39	$8,899,195.00	Disclosure SEC source: 0001140361-18-019416 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,696,685 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.06 to $25.58. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 11, 2018 Filed Apr 13, 2018 19:39 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	958,355	$23.55	$22,569,260.25	Disclosure SEC source: 0001140361-18-018582 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,346,185 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $22.85 to $23.55. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 06, 2018 Filed Apr 10, 2018 21:55 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	653	$1.36	$888.08	Disclosure SEC source: 0001387131-18-001515 · braunstein-form4_040618.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,433 F1 · shares: The 653 shares of Common Stock were issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. Director Compensation Policy in lieu of, at the reporting person's election, his pro-rated quarterly cash retainer and any meeting fees in the amount of $889. Read SEC document
March 29, 2018 Filed Apr 2, 2018 17:13 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	63,100	$22.47	$1,417,857.00	Disclosure SEC source: 0001140361-18-016473 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,387,830 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $22.35 to $22.64. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other reporting person undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
March 16, 2018 Filed Mar 20, 2018 21:41 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	GrantCommon Stock	6,780	$0.00	$0.00	Disclosure SEC source: 0001387131-18-001151 · braunstein-form4_031618.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,780 F1 · shares: The common stock represents shares issuable upon vesting of restricted stock units granted as part of the director's annual equity award with vesting beginning as of March 16, 2018, the date of the reporting person's appointment as a director. The restricted stock units vest in four equal quarterly installments on June 16, 2018, September 16, 2018, December 16, 2018 and March 16, 2019, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. F1 · balance_after: The common stock represents shares issuable upon vesting of restricted stock units granted as part of the director's annual equity award with vesting beginning as of March 16, 2018, the date of the reporting person's appointment as a director. The restricted stock units vest in four equal quarterly installments on June 16, 2018, September 16, 2018, December 16, 2018 and March 16, 2019, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. Read SEC document
February 21, 2018 Filed Feb 23, 2018 15:44 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	5,810	$24.00	$139,440.00	Disclosure SEC source: 0001140361-18-009829 · doc1.xml · nonDerivative · entry 3 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,324,730 F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $24.00 to $24.01. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
February 21, 2018 Filed Feb 23, 2018 15:44 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	278,402	$23.39	$6,511,822.78	Disclosure SEC source: 0001140361-18-009829 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,318,920 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $23.00 to $23.99. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
February 21, 2018 Filed Feb 23, 2018 15:44 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	37,788	$22.73	$858,921.24	Disclosure SEC source: 0001140361-18-009829 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,040,518 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $22.00 to $22.99. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other reporting person undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1, footnote 5 and footnote 6 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
January 07, 2018 Filed Jan 9, 2018 17:36 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	GrantStock Option (Right to Buy) · Derivative	10,000	$0.00 Strike: $59.14	$0.00	Disclosure SEC source: 0001209191-18-002984 · doc4.xml · derivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-06 F1 · derivative.exercise_date: The option fully vests on January 7, 2019, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. Read SEC document
August 09, 2017 Filed Aug 11, 2017 16:34 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	PurchaseCommon Stock	1,584	$50.09	$79,338.44	Disclosure SEC source: 0001209191-17-048604 · doc4.xml · nonDerivative · entry 3 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 971,000 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $49.815 to $50.39, inclusive. F2 · ownership.nature: These securities are held for the account of certain private investment funds (the "HEC Funds") for which Hudson Executive Capital LP, a Delaware limited partnership ("HEC"), acts as investment adviser. The Reporting Person controls the general partner of HEC and indirectly controls the general partner of the HEC Funds. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them. Read SEC document
August 09, 2017 Filed Aug 11, 2017 16:34 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	PurchaseCommon Stock	15,206	$49.21	$748,258.37	Disclosure SEC source: 0001209191-17-048604 · doc4.xml · nonDerivative · entry 2 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 969,416 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $48.73 to $49.58, inclusive. F2 · ownership.nature: These securities are held for the account of certain private investment funds (the "HEC Funds") for which Hudson Executive Capital LP, a Delaware limited partnership ("HEC"), acts as investment adviser. The Reporting Person controls the general partner of HEC and indirectly controls the general partner of the HEC Funds. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them. Read SEC document
August 09, 2017 Filed Aug 11, 2017 16:34 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	PurchaseCommon Stock	3,610	$48.06	$173,489.74	Disclosure SEC source: 0001209191-17-048604 · doc4.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 954,210 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $47.67 to $48.665, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (3), and (4) to this Form 4. F2 · ownership.nature: These securities are held for the account of certain private investment funds (the "HEC Funds") for which Hudson Executive Capital LP, a Delaware limited partnership ("HEC"), acts as investment adviser. The Reporting Person controls the general partner of HEC and indirectly controls the general partner of the HEC Funds. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them. Read SEC document
January 04, 2017 Filed Jan 6, 2017 17:08 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	GrantStock Option (right to buy) · Derivative	10,000	$0.00 Strike: $84.92	$0.00	Disclosure SEC source: 0001209191-17-002686 · doc4.xml · derivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-01-03 F1 · derivative.exercise_date: The option fully vests on January 4, 2018, subject to the reporting person's continuous service with the issuer as of the vesting date. Read SEC document
December 26, 2012 Filed Jan 4, 2013 20:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GiftCommon Stock	109,000	$0.00	$0.00	Disclosure SEC source: 0001225208-13-000786 · doc4.xml · nonDerivative · entry 6 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for children Disclosed balance after: 109,000 Read SEC document
December 26, 2012 Filed Jan 4, 2013 20:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GiftCommon Stock	109,000	$0.00	$0.00	Disclosure SEC source: 0001225208-13-000786 · doc4.xml · nonDerivative · entry 2 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,836 Read SEC document
December 21, 2012 Filed Jan 4, 2013 20:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GiftCommon Stock	24,000	$0.00	$0.00	Disclosure SEC source: 0001225208-13-000786 · doc4.xml · nonDerivative · entry 5 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse's Trust for Children Disclosed balance after: 24,000 Read SEC document
December 21, 2012 Filed Jan 4, 2013 20:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GiftCommon Stock	24,000	$0.00	$0.00	Disclosure SEC source: 0001225208-13-000786 · doc4.xml · nonDerivative · entry 4 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document
December 17, 2012 Filed Jan 4, 2013 20:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GiftCommon Stock	24,000	$0.00	$0.00	Disclosure SEC source: 0001225208-13-000786 · doc4.xml · nonDerivative · entry 3 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 24,000 Read SEC document
December 17, 2012 Filed Jan 4, 2013 20:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GiftCommon Stock	24,000	$0.00	$0.00	Disclosure SEC source: 0001225208-13-000786 · doc4.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579,836 Read SEC document
January 18, 2012 Filed Jan 20, 2012 23:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GrantStock Appreciation Rights · Derivative	168,729	$0.00 Strike: $35.61	$0.00	Disclosure SEC source: 0001225208-12-001770 · doc4.xml · derivative · entry 2 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,729 Underlying: Common Stock · 168,729 shares Expires 2022-01-18 F4 · kind: See Exhibit 99.2 for description of the Firm's bonus recovery policies applicable to these awards. F5 · derivative.exercise_date: Stock appreciation rights, which have a ten-year term, become exercisable in five equal installments beginning January 18, 2013. Shares resulting from exercise must be held at least five years from the grant date. Read SEC document
January 18, 2012 Filed Jan 20, 2012 23:02 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GrantRestricted Stock Units · Derivative	122,174	$0.00	$0.00	Disclosure SEC source: 0001225208-12-001770 · doc4.xml · derivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,174 Underlying: Common Stock · 122,174 shares Expires 2015-01-13 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2 · kind: See Exhibit 99.1 for description of the Firm's bonus recovery policies applicable to these awards. F3 · derivative.exercise_date: Restricted stock units vest 50% on January 13, 2014 and 50% on January 13, 2015. Read SEC document
January 13, 2012 Filed Jan 18, 2012 22:10 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	Tax withholdingCommon Stock	92,149	$35.53	$3,273,593.23	Disclosure SEC source: 0001225208-12-001544 · doc4.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,836 Read SEC document
January 19, 2011 Filed Jan 21, 2011 21:56 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GrantStock Appreciation Rights · Derivative	153,847	$0.00 Strike: $44.29	$0.00	Disclosure SEC source: 0001225208-11-003578 · doc4.xml · derivative · entry 2 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,847 Underlying: Common Stock · 153,847 shares Expires 2021-01-19 F2 · kind: See Exhibit 99.1 for description of the Firm's bonus recovery policies applicable to these awards. F4 · derivative.exercise_date: Stock appreciation rights, which have a ten-year term, become exercisable in five equal installments beginning January 19, 2012. Shares resulting from exercise must be held at least five years from the grant date. Read SEC document
January 19, 2011 Filed Jan 21, 2011 21:56 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	GrantRestricted Stock Units · Derivative	130,067	$0.00	$0.00	Disclosure SEC source: 0001225208-11-003578 · doc4.xml · derivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,067 Underlying: Common Stock · 130,067 shares Expires 2014-01-13 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2 · kind: See Exhibit 99.1 for description of the Firm's bonus recovery policies applicable to these awards. F3 · derivative.exercise_date: Restricted stock units vest 50% on January 13, 2013 and 50% on January 13, 2014. Read SEC document
January 13, 2011 Filed Jan 19, 2011 00:13 UTC	JPMORGAN CHASE & CO JPM · Entity 2795	Tax withholdingCommon Stock	151,966	$44.57	$6,773,124.62	Disclosure SEC source: 0001225208-11-003226 · doc4.xml · nonDerivative · entry 1 Braunstein Douglas L · CIK 0001495110 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 695,985 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.